Pain
News
Romosozumab gets FDA approval for treating osteoporosis
The pair of injections mainly works by encouraging new bone formation.
Conference Coverage
NIH’s HEAL initiative seeks coordinated effort to tackle pain, addiction
MILWAUKEE – The two aims of research under the initiative are to improve treatments for misuse and addiction, and to enhance pain management.
Conference Coverage
Addressing anxiety helps youth with functional abdominal pain disorders
MILWAUKEE – Tackling comorbid anxiety reduced pain, disability, and anxiety.
Applied Evidence
High ankle sprains: Easy to miss, so follow these tips
Misdiagnosis can result in increased loss of play time and chronic ankle dysfunction. Here are the physical exam maneuvers and imaging options to...
Applied Evidence
It’s time to start asking all patients about intimate partner violence
Many people endure a menacing or violent romantic partner—yet few physicians ask about this risk, or actual harm. Here is a roadmap for screening...
From the Journals
Rituximab does not improve fatigue symptoms of ME/CFS
Results from the phase 3 RituxME trial found no difference in fatigue score symptoms after 24 months.
Feature
Report calls for focus on ‘subpopulations’ to fight opioid epidemic
“Methadone, buprenorphine, and extended-release naltrexone ... save lives” but most people with OUD get no treatment, new report says.
From the Journals
Surge of gabapentinoids for pain lacks supporting evidence
Review of 54 papers for gabapentin and 30 for pregabalin finds little evidence for effective pain control in off-label uses.
Video
Through the eyes of migraine: Ocular considerations
STOWE, VT. – Dr. Kathleen Digre discusses the eye’s role in migraine.
Video
CGRP drugs: How is it going?
STOWE, VT. – Dr. Peter McAllister summarizes postmarketing experiences with CGRP monoclonal antibodies for migraine prevention.
Conference Coverage
Opioid overdose risk greater among HIV patients